Arie Visser

417 total citations
11 papers, 272 citations indexed

About

Arie Visser is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Arie Visser has authored 11 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Cell Biology. Recurrent topics in Arie Visser's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Arie Visser is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Arie Visser collaborates with scholars based in Netherlands, France and Germany. Arie Visser's co-authors include Luc Brunsveld, G.M.T. Vogel, M Carraz, Rolf Rose, D.G. Meuleman, Christian Ottmann, R.G.M. van Amsterdam, Peter D. J. Grootenhuis, C. A. A. VAN BOECKEL and Hans Lucas and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Arie Visser

11 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arie Visser Netherlands 9 113 90 63 59 57 11 272
Koc-Kan Ho United States 12 328 2.9× 64 0.7× 13 0.2× 44 0.7× 14 0.2× 17 476
Denise M. Wilcox United States 6 128 1.1× 110 1.2× 29 0.5× 66 1.1× 12 0.2× 8 338
E. Széll Hungary 6 175 1.5× 77 0.9× 156 2.5× 25 0.4× 2 0.0× 15 342
Andiliy Lai United States 6 167 1.5× 107 1.2× 87 1.4× 14 0.2× 22 0.4× 7 336
Jefferson R. McCowan United States 10 262 2.3× 162 1.8× 22 0.3× 16 0.3× 5 0.1× 19 454
David K. Miyamoto United States 8 320 2.8× 110 1.2× 24 0.4× 14 0.2× 30 0.5× 9 406
Masanobu Komiya Japan 10 146 1.3× 70 0.8× 69 1.1× 12 0.2× 47 0.8× 18 376
Piergiorgio Pettazzoni Italy 12 386 3.4× 37 0.4× 63 1.0× 20 0.3× 20 0.4× 18 525
Hélène Morin Canada 10 163 1.4× 16 0.2× 10 0.2× 71 1.2× 9 0.2× 20 278
Monica Andreoli United States 7 232 2.1× 60 0.7× 52 0.8× 35 0.6× 6 0.1× 9 390

Countries citing papers authored by Arie Visser

Since Specialization
Citations

This map shows the geographic impact of Arie Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Visser more than expected).

Fields of papers citing papers by Arie Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arie Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Visser. The network helps show where Arie Visser may publish in the future.

Co-authorship network of co-authors of Arie Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Arie Visser. A scholar is included among the top collaborators of Arie Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie Visser. Arie Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rose, Rolf, et al.. (2010). Synthesis and Crystal Structure of a Phosphorylated Estrogen Receptor Ligand Binding Domain. ChemBioChem. 11(16). 2251–2254. 66 indexed citations
3.
Adang, Anton E.P., G.M.T. Vogel, Peter D. J. Grootenhuis, et al.. (2002). Unique Overlap in the Prerequisites for Thrombin Inhibition and Oral Bioavailability Resulting in Potent Oral Antithrombotics. Journal of Medicinal Chemistry. 45(20). 4419–4432. 30 indexed citations
4.
Lormeau, J C, et al.. (1997). DETERMINATION OF THE ANTI-FACTOR Xa ACTIVITY OF THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 AND OF TWO STRUCTURAL ANALOGUES. Thrombosis Research. 85(1). 67–75. 13 indexed citations
5.
Gadella, Theodorus W. J., et al.. (1996). Proceedings of fluorescence lifetime imaging meeting. Scanning. 18(1). 55–61. 4 indexed citations
6.
Visser, Arie, et al.. (1995). Peptide-derived transition state analogue inhibitors of thrombin; Synthesis, activity and selectivity. Bioorganic & Medicinal Chemistry. 3(8). 1099–1114. 10 indexed citations
7.
Amsterdam, R.G.M. van, et al.. (1995). Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of Heparin. Arteriosclerosis Thrombosis and Vascular Biology. 15(4). 495–503. 28 indexed citations
8.
Westerduin, Pieter, C. A. A. VAN BOECKEL, Jan E. M. Basten, et al.. (1994). Feasible synthesis and biological properties of six ‘non-glycosamino’ glycan analogues of the antithrombin III binding heparin pentasaccharide. Bioorganic & Medicinal Chemistry. 2(11). 1267–1280. 61 indexed citations
9.
Theunissen, Henri, et al.. (1993). Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.. Journal of Biological Chemistry. 268(12). 9035–9040. 29 indexed citations
10.
Visser, Arie & D.G. Meuleman. (1990). Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans. Thrombosis Research. 58(5). 469–479. 8 indexed citations
11.
Visser, Arie & T.A.J. Payens. (1982). On the kinetics of the thrombin‐controlled polymerization of fibrin. FEBS Letters. 142(1). 35–38. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026